|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the MRVL 10-K filed Jul 2, 2007. Evergreen Grants: During the Relevant Period, there were eight
Evergreen grant dates. Substantially all employees are entitled to these grants
for retention purposes. There were two Evergreen grant dates in both fiscal
2003 and 2004. There was evidence of amendments to the recipients and/or the
number of options subsequent to the original grant date. In all cases, the
definitive lists of award recipients could not be reasonably determined until
after the original grant date, impacting 54,702,828 options. Consequently, all
Evergreen grants were re-measured on subsequent dates when the granting process
was considered to be finalized. For purposes of the restatement, the Company
used the date the grant was submitted to stock administration for processing,
which typically indicated the conclusion of the grant process. The last date of
submission was used unless the submitted change was proven to be purely
administrative in nature and unrelated to the terms of the grant. Absent this
supporting documentation, the date the grant entry was created in the option
database was used. In substantially all instances, the stock price on the
former date was lower than the price on the appropriate measurement date. The
last Evergreen grant (totaling 7,215,056 options) occurred during fiscal 2007
and the effects on the restatement were included in the restated fair value of
the affected grants under SFAS 123R, increasing the grant date fair value of
affected options by $0.31 per share.
This excerpt taken from the MRVL 10-Q filed Jul 2, 2007. Evergreen Grants:
During the
Relevant Period, there were eight Evergreen grant dates. Substantially all employees are entitled to
these grants for retention purposes. There
were two Evergreen grant dates in both fiscal 2003 and 2004. There was evidence of amendments to the
recipients and/or the number of options subsequent to the grant date. In all cases, the definitive lists of award
recipients could not be reasonably determined until after the original grant
date, impacting 54,702,828 options.
Consequently, all Evergreen grants were re-measured on subsequent dates
when the granting process was considered to be finalized. For purposes of the restatement, we used the
date the grant was submitted to stock administration for processing, which
typically indicated the conclusion of the grant process. The last date of submission was used unless
the submitted change was proven to be purely administrative in nature and
unrelated to the terms of the grant.
Absent this supporting documentation, the date the grant entry was
created in our option database was used.
In substantially all instances, the stock price on the former date was
lower than the price on the appropriate measurement date. The last Evergreen grant (totaling 7,215,056 options)
occurred during fiscal 2007 and the effects on the restatement were included in
the restated fair value of the affected grants under SFAS 123R, increasing the
grant date fair value of affected options by $0.31 per share.
This excerpt taken from the MRVL 10-Q filed Jul 2, 2007. Evergreen Grants:
During the
Relevant Period, there were eight Evergreen grant dates. Substantially all employees are entitled to
these grants for retention purposes.
There were two Evergreen grant dates in both fiscal 2003 and 2004. There was evidence of amendments to the
recipients and/or the number of options subsequent to the original grant date. In all cases, the definitive lists of award
recipients could not be reasonably determined until after the original grant
date, impacting 54,702,828 options.
Consequently, all Evergreen grants were re-measured on subsequent dates
when the granting process was considered to be finalized. For purposes of the restatement, we used the
date the grant was submitted to stock administration for processing, which
typically indicated the conclusion of the grant process. The last date of submission was used unless
the submitted change was proven to be purely administrative in nature and
unrelated to the terms of the grant.
Absent this supporting documentation, the date the grant entry was created
in our option database was used. In
substantially all instances, the stock price on the former date was lower than
the price on the appropriate measurement date.
The last Evergreen grant (totaling 7,215,056 options) occurred during
fiscal 2007 and the effects on the restatement were included in the restated
fair value of the affected grants under SFAS 123R, increasing the grant date
fair value of affected options by $0.31 per share.
This excerpt taken from the MRVL 10-Q filed Jul 2, 2007. Evergreen Grants:
During the
Relevant Period, there were eight Evergreen grant dates. Substantially all employees are entitled to
these grants for retention purposes.
There were two Evergreen grant dates in both fiscal 2003 and 2004. There was evidence of amendments to the
recipients and for the number of options subsequent to the grant date. In all cases, the definitive lists of award
recipients grant date could not be reasonably determined until after the original
grant date, impacting 54,702,828 options.
Consequently, all Evergreen grants were re-measured on subsequent dates
when the granting process was considered to be finalized. For purposes of the restatement, we used the
date the grant was submitted to stock administration for processing, which
typically indicated the conclusion of the grant process. The last date of submission was used unless
the submitted change was proven to be purely administrative in nature and
unrelated to the terms of the grant.
Absent this supporting documentation, the date the grant entry was
created in our option database was used.
In substantially all instances, the stock price on the former date was
lower than the price on the appropriate measurement date. The last Evergreen grant (totaling 7,215,056 options)
occurred during fiscal 2007 and the effects on the restatement were included in
the restated fair value of the affected grants under SFAS 123R, increasing the
grant date fair value of affected options by $0.31 per share.
| EXCERPTS ON THIS PAGE:
RELATED TOPICS for MRVL: |
| |||||||
